Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01
Published February 27, 2019 · Recall initiated: January 31, 2019
Summary
FDA records drug Class II recall D-0507-2019, published February 27, 2019 and initiated January 31, 2019. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 10,656 bottles; Lot: Lot #: C802676, Exp 03/20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Out of specification results observed for high dissolution.
What to do
Voluntary: Firm initiated · Letter
Get an email if DIVALPROEX SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIVALPROEX SODIUM
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- U.S.A. Nationwide
- Lot
- Lot #: C802676, Exp 03/20
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADivalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by:July 29, 2026
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: AmnealApril 3, 2024
- FDADivalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, ManufacturedAugust 31, 2022
- FDADivalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun PharmaceuticalAugust 3, 2022
- FDADiltiazem HCl Extended-Release Capsules, USP 180mg, Packaged in a) 100-count bottles (NDC 0378-5280-01), andFebruary 27, 2019
- FDACiclopirox shampoo 1%,120 mL bottle, Rx only, Manufactured By Perrigo Bronx, NY 10457 Distributed by PerrigoFebruary 27, 2019
Questions about this recall
Was Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01 recalled?
Yes. FDA published recall D-0507-2019 on February 27, 2019. Reported hazard: Failed Dissolution Specifications: Out of specification results observed for high dissolution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIVALPROEX SODIUM.